Association between leukocyte telomere length and glioma risk: A case-control study

Neuro-Oncology

Volumn 16, Issue 4, 2014, Pages 505-512

  Wang, Shaolong ^a   Chen, Yibing ^b   Qu, Falin ^b   He, Shiming ^c   Huang, Xiaojun ^b   Jiang, Hequn ^a   Jin, Tianbo ^d   Wan, Shaogui ^e   Xing, Jinliang ^b  

^a CHENGDU MEDICAL COLLEGE   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d NORTHWEST UNIVERSITY   (China)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Glioma risk; Logistic regression model; Real time PCR; Telomere length

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; EPENDYMOMA; FAMILY HISTORY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PLEOMORPHIC XANTHOASTROCYTOMA; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TELOMERE HOMEOSTASIS; TELOMERE LENGTH;

GLIOMA RISK; LOGISTIC REGRESSION MODEL; REAL-TIME PCR; TELOMERE LENGTH;

ADULT; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; LEUKOCYTES; MALE; NEOPLASM GRADING; ODDS RATIO; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84896901883     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not240     Document Type: Article

References (47)

1. Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol. 2009;472: 323-342.
2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008; 359(5):492-507.
3. Gu J, Liu Y, Kyritsis AP, Bondy ML. Molecular epidemiology of primary brain tumors. Neurotherapeutics. 2009;6(3):427-435.
4. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst. 2007;99(20):1544-1550.
5. Calboli FC, Cox DG, Buring JE, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies J Natl Cancer Inst.2011;103(21):1588-1595.
6. Xu L, Li S, Stohr BA. The role of telomere biology in cancer. Annu Rev Pathol. 2013;8:49-78.
7. Hug N, Lingner J. Telomere length homeostasis. Chromosoma. 2006; 115(6):413-425.
8. Nordfjall K, Larefalk A, Lindgren P, Holmberg D, Roos G. Telomere length and heredity: Indications of paternal inheritance. Proc Natl Acad Sci U S A. 2005;102(45):16374-16378.
9. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366(9486):662-664.
10. Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008; 9(11):1048-1057.
11. Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45(4):422-427.
12. Heeg S, Hirt N,Queisser A, et al. EGFR overexpression induces activation of telomerase via PI3 K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis. Cancer Sci. 2011;102(2):351-360.
13. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274):458-460.
14. Greenberg RA, Chin L, Femino A, et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 1999;97(4):515-525.
15. Feldser DM, Greider CW. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell. 2007;11(5):461-469.
16. Velicescu M, Yu J, Herbert BS, Shay JW, Granada E, Dubeau L. Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells. Cancer Res. 2003;63(18): 5813-5820.
17. O'Hagan RC, Chang S, Maser RS, et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2002;2(2):149-155.
18. Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009;361(24): 2353-2365.
19. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406(6796):641-645.
20. Svenson U, Roos G. Telomere length as a biological marker in malignancy. Biochim Biophys Acta. 2009;1792(4):317-323.
21. McGrath M,Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers. 2007;16(4):815-819.
22. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci. 2008;99(7):1385-1389.
23. Xing J, Ajani JA, Chen M, et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res. 2009;2(5): 459-465.
24. Hou L, Savage SA,Blaser MJ,et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2009;18(11):3103-3109.
25. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003;95(16):1211-1218.
26. Mirabello L, Garcia-Closas M, Cawthon R, et al. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control. 2010;21(1):77-82.
27. Shao L, Wood CG, Zhang D, et al. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol. 2007;178:1492-1496.
28. Liu J, Yang Y, Zhang H, et al. Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis. Cancer. 2011;117(18):4247-4256.
29. Gramatges MM, Telli ML, Balise R, Ford JM. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers . 2010; 19(2):605-613.
30. Lan Q, Cawthon R, Gao Y, et al. Longer Telomere Length in Peripheral White Blood Cells Is Associated with Risk of Lung Cancer and the rs2736100 (CLPTM1L-TERT) Polymorphism in a Prospective Cohort Study amongWomen in China. PloS One. 2013;8(3):e59230.
31. Hou L, Zhang X, Gawron AJ, Liu J. Surrogate tissue telomere length and cancer risk: shorter or longer?. Cancer Lett. 2012;319(2):130-135.
32. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res. 2007; 67(11):5538-5544.
33. Mirabello L, Richards EG, Duong LM, et al. Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet. 2011;2(1):19-29.
34. Widmann TA, Herrmann M, Taha N, Konig J, Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol. 2007;35(6):939-946.
35. Han J, Qureshi AA, Prescott J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009;129(2): 415-421.
36. Lan Q, Cawthon R, Shen M, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 2009;15(23):7429-7433.
37. Skinner HG, Gangnon RE, Litzelman K, et al. Telomere length and pancreatic cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21(11):2095-2100.
38. Qu S,WenW, Shu XO, et al. Association of Leukocyte Telomere Length With Breast Cancer Risk: Nested Case-Control Findings From the Shanghai Women's Health Study. Am J Epidemiol. 2013;177(7): 617-624.
39. Cui Y, Cai Q, Qu S, et al. Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1807-1813.
40. Bailey SM, Murnane JP. Telomeres, chromosomeinstability and cancer. Nucleic Acids Res. 2006;34(8):2408-2417.
41. Gonzalez-Suarez E, Flores JM, Blasco MA. Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol Cell Biol. 2002;22(20):7291-7301.
42. Li G, Jin TB, Wei XB, et al. Selected polymorphisms of GSTP1 and TERT were associated with glioma risk in Han Chinese. Cancer Epidemiol. 2012;36(6):525-527.
43. Li G, Jin T, Liang H, et al. RTEL1 tagging SNPs and haplotypes were associated with glioma development. Diagn Pathol. 2013; 8:83.
44. Walsh KM, Rice T, Decker PA, et al. Genetic variants in telomeraserelated genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol. 2013;15(8):1041-1047.
45. Maxwell F, McGlynn LM, Muir HC, et al. Telomere attrition and decreased fetuin-A levels indicate accelerated biological aging and are implicated in the pathogenesis of colorectal cancer. Clini Cancer Res. 2011;17(17):5573-5581.
46. Fu X, Wan S, Hann HW, et al. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur J Cancer. 2012;48(7):1014- 1022.
47. Zhou K, Liu Y, Zhang H, et al. XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int J Cancer.2009;124(12):2948-2953.